CA Market News
1月前
EcoSynthetix Reports 2026 First Quarter ResultsMay 5, 2026 5:00 PM
PR Newswire (Canada) BURLINGTON, ON, May 5, 2026 /CNW/ - EcoSynthetix Inc. (TSX: ECO) ("EcoSynthetix" or the "Company"), a renewable chemicals company that produces a portfolio of commercially proven bio-based products, today announced its financial and operational results for the three months (Q1 2026) ended March 31, 2026. Financial references are in U.S. dollars unless otherwise indicated.Highlights
(Comparison periods in each case are the three months ended March 31, 2025)Recorded net sales of $3.8 million, down 7%, primarily due to lower sales volumes.Sales volumes have been impacted year-to-date primarily due to an inventory buildup by key accounts in the prior year and challenging macro conditions in the Company's end markets.The leading global pulp producer customer successfully completed an industrial-scale trial at a second, larger facility during the period.Trial activity is encouraging across a range of top tier global pulp, tissue and packaging producers.Recorded an Adjusted EBITDA1 loss of $0.3 million, a 32% improvement.Purchased and cancelled 245,095 common shares in Q1 2026, under the normal course issuer bid for total consideration of $0.6 million. Maintained a strong balance sheet with cash and term deposits of $29.8 million as at March 31, 2026."The momentum we built in 2025 remains firmly intact. While temporary dynamics with key accounts are impacting near-term volumes, we remain confident in accelerating growth in the second half of the year. This confidence is supported by consistent feedback from key accounts, who continue to recognize and validate the positive impact our bio-based polymers bring to their respective end markets," said Jeff MacDonald, CEO of EcoSynthetix. "Our pipeline of trial activity remains robust, including in the tissue and pulp end markets. The leading global pulp manufacturer, which is commercial with our SurfLock™ strength aids at one facility today, successfully completed trials at a second, larger facility in the quarter. We believe pulp represents a key growth driver for us supported by a compelling economic case for conversion to our bio-based solutions. In the tissue end market, we continue to see encouraging trial activity across a range of top tier global producers. The international retailer using our wood composites binder in its particleboard production remains committed to converting its supply chain to bio-based glues by 2030. And our marketing & development partner in personal care, Dow, reports strong engagement from manufacturers for its all-natural MaizeCare™ brand polymers. As we navigate near-term volatility, our key commercial priority is supporting our existing accounts and converting trial prospects into long-term commercial relationships. We believe this disciplined execution positions us well for the second half of 2026 with improving volume growth and broader adoption across our end markets."Financial SummaryNet SalesNet sales were $3.8 million for Q1 2026, compared to $4.0 million for the corresponding period in 2025. The 7% change was primarily due to lower volumes of $0.7 million, or 18%, partially offset by a higher average price which increased sales $0.4 million. The lower volumes were mainly attributable to customer inventory de-stocking and challenging macro conditions in end markets during the period. The 11% increase in sales due to average selling price was driven by foreign exchange fluctuations and an improved product mix.Gross ProfitGross profit was $0.9 million for Q1 2026, unchanged from the corresponding period in 2025, as a higher average selling price was offset by lower volumes and higher manufacturing costs.Gross profit as a percentage of sales was 24.6% for Q1 2026, compared to 21.5% in the corresponding period in 2025. Gross profit as a percentage of sales adjusted for manufacturing depreciation was 30.6% for Q1 2026, compared to 27.2% for the corresponding period in 2025. The improvement in each measure was primarily due to a higher average selling price, partially offset by higher manufacturing costs.Selling, General and AdministrativeSelling, general and administrative expenses (SG&A) were $1.6 million for Q1 2026, compared to $1.5 million for the corresponding period in 2025. The 9% change was primarily due to higher salaries and benefits and other miscellaneous costs offset by lower repairs and maintenance.Research and DevelopmentResearch and development (R&D) costs were $0.2 million for Q1 2026, compared to $0.4 million for the corresponding period in 2025. The change primarily relates to refundable SR&ED tax credits recognized in the current period, and prior year fiscal period, in accordance with Bill C-15, which was enacted into law in Canada in March 2026. R&D expense as a percentage of sales was 5% for Q1 2026. The Company's R&D efforts continue to focus on further enhancing value for our existing products and expanding addressable opportunities.Adjusted EBITDA1Adjusted EBITDA was $(0.3) million for Q1 2026, compared to $(0.5) million for the corresponding period in 2025. The 32% improvement was primarily due to higher gross profit and lower operating costs adjusted for non-cash items when compared to the prior period. Net LossNet loss was $0.6 million, or $0.01 per common share, for Q1 2026, unchanged from the corresponding period in 2025.Liquidity Cash on hand and term deposits were $29.8 million as at March 31, 2026, compared to $29.6 million as at December 31, 2025. The Company purchased and cancelled 245,095 common shares under the NCIB during Q1 2026, for consideration of $0.6 million.Notice of Conference Call EcoSynthetix will host a conference call Wednesday, May 6, at 8:30 am ET to discuss its financial results. Jeff MacDonald, CEO, and Robert Haire, CFO, will co-chair the call. All interested parties can instantly join the call by phone, by following the URL https://emportal.ink/4tjCrDG to easily register and be connected into the conference call automatically or the conventional method by dialling (416) 945-7677 or (888) 699-1199 with the conference identification of 15947#. Please dial in 15 minutes prior to the call to secure a line. A live audio webcast of the conference call will also be available at www.ecosynthetix.com or https://app.webinar.net/n9KZB9rmdM7. The presentation will be accompanied by slides, which will be available via the webcast link and the Company's website. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast.1Non-IFRS Financial MeasuresThis press release makes reference to certain non-IFRS measures. These non-IFRS measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing a further understanding of results of operations of EcoSynthetix from management's perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the financial information of EcoSynthetix reported under IFRS. The Company uses non-IFRS measures such as Adjusted EBITDA to provide investors with a supplemental measure of operating performance and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also believes that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of issuers. Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess the Company's ability to meet its capital expenditure and working capital requirements.Adjusted EBITDA is not a measure recognized under IFRS and does not have a standardized meaning prescribed by IFRS. See "IFRS and Non-IFRS Measures." The Company presents Adjusted EBITDA because the Company believes it facilitates investors' use of operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting relative interest expense), the book amortization of intangibles (affecting relative amortization expense) and the age and book value of property and equipment (affecting relative depreciation expense). The Company also presents Adjusted EBITDA because it believes it is frequently used by securities analysts, investors and other interested parties as a measure of financial performance. Adjusted EBITDA as presented herein are not recognized measures under IFRS and should not be considered as an alternative to operating income or net income as measures of operating results or an alternative to cash flows as measures of liquidity. Adjusted EBITDA is defined as consolidated net income (loss) before net interest expense, income taxes, depreciation, amortization, gain or loss on disposals of property, plant and equipment and other non-cash expenses and charges deducted in determining consolidated net income (loss).The following table reconciles net loss to Adjusted EBITDA (loss) for the three months ended March 31, 2026, and March 31, 2025:
Three months ended
March 31, 2026Three months ended
March 31, 2025Net loss(592,087)(606,526)Depreciation296,888270,403Share-based compensation219,793204,662Interest income(265,662)(369,550)Adjusted EBITDA (loss)(341,068)(501,011)About EcoSynthetix Inc. (www.ecosynthetix.com) EcoSynthetix offers a range of sustainable engineered biopolymers that allow customers to reduce their use of harmful materials, such as formaldehyde and styrene-based chemicals. The Company's flagship products, DuraBind™, Surflock™, Bioform™, and EcoSphere®, are used to manufacture wood composites, personal care, paper, tissue and packaging products, and enable performance improvements, economic benefits and carbon footprint reduction. The Company is publicly traded on the Toronto Stock Exchange (T:ECO).Forward-Looking StatementsCertain statements in this Press Release constitute "forward-looking" statements that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, objectives or achievements of the Company, or industry results, to be materially different from any future results, performance, objectives or achievements expressed or implied by such forward looking statements. The forward-looking statements in this Press Release include, but are not limited to, statements regarding the Company's plans to execute its commercial strategy, deliver meaningful growth across all three product categories, convert high-value strategic prospects into customers, and other statements regarding the Company's plans and expectations in 2026. These statements reflect our current views regarding future events and operating performance and are based on information currently available to us, and speak only as of the date of this Press Release. These forward-looking statements involve a number of risks, uncertainties and assumptions and should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such performance or results will be achieved. Those assumptions and risks include, but are not limited to, the Company's ability to successfully allocate capital as needed and to develop new products, as well as the fact that our results of operations and business outlook are subject to significant risk, volatility and uncertainty. Many factors could cause our actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including the factors identified in the "Risk Factors" section of the Company's Annual Information Form dated February 17, 2026. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described in this Press Release as intended, planned, anticipated, believed, estimated or expected. Unless required by applicable securities law, we do not intend and do not assume any obligation to update these forward-looking statements.EcoSynthetix Inc.
Consolidated Balance Sheets
(expressed in US dollars)
March 31,
2026December 31,
2025Assets
Current assets
Cash8,447,0248,420,285Term deposits21,328,55221,161,145Accounts receivable 1,762,3023,234,911Inventory3,969,2933,767,661Prepaid expenses245,388204,272
35,752,55936,788,274
Non-current assets
Property, plant and equipment 5,935,8945,943,242
Total assets41,688,45342,731,516
Liabilities
Current liabilities
Trade accounts payables and accrued liabilities 1,738,1022,355,358
Non-current liabilities
Lease liability1,655,9951,786,798
Total liabilities3,394,0974,142,156Shareholders' Equity
Common shares 489,452,620488,725,570Contributed surplus10,781,84311,211,810Accumulated deficit(461,940,107)(461,348,020)Total shareholders' equity 38,294,35638,589,360
Total liabilities and shareholders' equity 41,688,45342,731,516 EcoSynthetix Inc. Consolidated Statements of Operations and Comprehensive LossFor the three months ended March 31, 2026 and 2025(expressed in US dollars)
Three months ended March 31,
20262025
Net sales3,774,4394,042,161
Cost of sales2,844,4863,174,122
Gross profit on sales929,953868,039
Expenses
Selling, general and administrative1,595,7471,459,547Research and development191,955384,568
1,787,7021,844,115
Loss from operations(857,749)(976,076)
Net interest income265,662369,550
Net loss and comprehensive loss(592,087)(606,526)
Basic and diluted loss per common share (0.01)(0.01)Weighted average number of common shares outstanding58,999,36158,531,759 EcoSynthetix Inc. Consolidated Statements of Cash FlowsFor the three months ended March 31, 2026 and 2025(expressed in US dollars)
Three months ended March 31,
20262025Cash provided by (used in)
Operating activities
Net loss and comprehensive loss(592,087)(606,526)Items not affecting cash
Depreciation296,888270,403 Share-based compensation 219,793204,662 Other 17,413(34,882)Changes in non-cash working capital
Accounts receivable1,472,609(37,374) Inventory(187,398)(634,768) Prepaid expenses(41,116)(12,783) Trade accounts payables and accrued liabilities (680,464)445,088Interest on term deposits
Interest received on term deposits645,223841,794 Accrued interest on term deposits(231,740)(314,075)
919,121121,539
Investing activities
Purchase of property, plant and equipment(239,247)(23,165)Receipts on matured term deposits17,352,27416,550,000Purchase of term deposits(17,933,164)(17,280,000)
(820,137)(753,165)
Financing activities
Payments made on lease liability(99,717)(79,442)Common shares repurchased(586,464)(333,842)Exercise of common share options663,75443,238
(22,427)(370,046)
Effect of exchange rate changes on cash (49,818)37,059
Change in cash during the period 26,739(964,613)
Cash - Beginning of period8,420,2857,721,403
Cash - End of period 8,447,0246,756,790 SOURCE EcoSynthetix Inc. Original: EcoSynthetix Reports 2026 First Quarter Results
CA Market News
3月前
EcoSynthetix Reports 2025 Fourth Quarter and Year End ResultsFebruary 19, 2026 5:00 PM
PR Newswire (Canada)
BURLINGTON, ON, Feb. 19, 2026 /CNW/ - EcoSynthetix Inc. (TSX: ECO) ("EcoSynthetix" or the "Company"), a renewable chemicals company that produces a portfolio of commercially proven bio-based products, today announced its financial and operational results for the three months (Q4 2025) and twelve months (FY 2025) ended December 31, 2025. Financial references are in U.S. dollars unless otherwise indicated.
Highlights
(Comparison periods in each case are the three months and twelve months ended December 31, 2024)Recorded net sales of $5.9 million, up $0.5 million or 9%, and $20.8 million, up $2.3 million or 12%, in Q4 2025 and FY 2025 respectively.Recorded Adjusted EBITDA1 of $0.5 million, up $0.4 million, and $0.4 million, up $1.3 million, in Q4 2025 and FY 2025 respectively.Won two new commercial accounts in Europe for SurfLock™ strength aids in the tissue end market through a recently added distributor relationship in Q4 2025. Eight new mills adopted usage of SurfLock™ in 2025.Received additional purchase orders for SurfLock from a leading global pulp manufacturer in Q4 2025, including an order to support production trials at a second mill.Experienced increased demand across all strategic end markets, achieving the highest annual sales to date in wood composites, personal care, tissue and pulp.Achieved climate positive operations in 2025, driven by increased customer adoption of our low carbon products, resulting in the avoidance of more than 125% of the Company's associated carbon emissions.Purchased and cancelled 117,833 and 463,468 common shares in Q4 2025 and FY 2025, respectively, under the normal course issuer bid for total consideration of $0.4 million and $1.4 million.Maintained a strong balance sheet with cash and term deposits of $29.6 million as at December 31, 2025."We have successfully broadened and deepened our penetration into our key strategic end markets of pulp, tissue, wood composites and personal care. The strong double-digit growth we experienced in each of these end markets has allowed us to lap the deterioration in our legacy end markets," said Jeff MacDonald, CEO of EcoSynthetix. "The business is in a better position today, with stronger demand from the key accounts and partners in each end market. In 2025, we also expanded our sales and distribution channels with new commercial accounts and sales infrastructure in new countries. Our bio-based technology offers comparable or better performance and value to conventional petroleum-based binders with carbon footprint and all-natural advantages. The performance benefits we offer pulp and tissue manufacturers and our personal care partner, Dow, can have a significant economic impact to them. The carbon footprint advantage we offer our key strategic wood composites account, plays directly into that retailer's market-leading sustainability program. As adoption of our bio-based polymers build, we're supporting these accounts as they increase usage rates in their initial facilities and convert other lines to our biopolymer platform."Financial SummaryNet SalesNet sales were $5.9 million and $20.8 million for Q4 2025 and FY 2025, respectively, compared to $5.4 million and $18.5 million for the corresponding periods in 2024. The $0.5 million increase, or 9% improvement in the quarterly period was primarily due to a higher average selling price, driven by improved product mix. The $2.3 million increase, or 12% improvement, in the annual period was primarily due to higher volumes of $1.6 million, or 9%, and a higher average selling price which increased sales $0.7 million, or 3%. The increase in volume during the annual period was primarily due to increased demand for the Company's products sold into the wood composites, pulp and tissue end markets, while the higher average selling price was driven by improved product mix.Gross ProfitGross profit was $2.0 million and $6.0 million for Q4 2025 and FY 2025, respectively, compared to $1.6 million and $5.3 million for the corresponding periods in 2024. The 27% improvement in the quarterly period, was primarily due a higher average selling price, partially offset by higher manufacturing costs, both attributable to changes in product mix. The $0.7 million increase, or 14%, in the annual period was primarily due to a higher average selling price and increased sales volumes, partially offset by higher manufacturing costs associated with product mix.Gross profit as a percentage of sales was 33.9% and 29.0% for Q4 2025 and FY 2025, respectively, compared to 28.9% and 28.6% in the corresponding periods last year. Gross profit as a percentage of sales adjusted for manufacturing depreciation was 38.1% and 33.6% for Q4 2025 and FY 2025, respectively, compared to 34.4% and 33.2% for the corresponding periods in 2024. The improvements in these measures in both periods were primarily attributable to a higher average selling price, partially offset by higher manufacturing costs.Selling, General and AdministrativeSelling, general and administrative expenses (SG&A) were $1.7 million and $6.2 million for Q4 2025 and FY 2025, respectively, compared to $1.8 million and $6.5 million for the corresponding periods in 2024. The improvement in the annual period was primarily due to asset relocation costs incurred in the prior year.Research and DevelopmentResearch and development (R&D) costs were $0.4 million in Q4 2025, in line with the prior year period and $1.6 million for FY 2025, compared to $2.0 million in the corresponding period in 2024. The change in the annual period was primarily attributable to higher product scale-up costs incurred in the prior year, as well as lower asset depreciation. R&D expense as a percentage of sales was 7% and 8% in Q4 2025 and YTD 2025, respectively, compared to 7% and 11% in the corresponding periods in 2024. The Company's R&D efforts continue to focus on further enhancing value for our existing products and expanding addressable opportunities.Adjusted EBITDA1Adjusted EBITDA was $0.5 million for Q4 2025 and $0.4 million for FY 2025, compared to $0.1 million and an Adjusted EBITDA loss of $0.9 million in the corresponding periods last year. The improvements in each period of $0.4 million and $1.3 million, respectively, were primarily due to higher gross profit, adjusted for non-cash items, as well as lower operating costs in the annual period. Net Income (Loss)Net income was $0.2 million, or $0.00 per common share, for Q4 2025 compared to a net loss of $0.2 million, or $0.00 per common share, for the same period last year. Net loss was $0.4 million, or $0.01 per common share, for FY 2025 compared to a net loss of $1.4 million, or $0.02 per common share, for FY 2024. The improvements for each period were primarily due a reduction in loss from operations, partially offset by a decrease in net interest income due to declining interest rates. Liquidity Cash on hand and term deposits were $29.6 million as at December 31, 2025, compared to $32.2 million as at December 31, 2024. The Company purchased and cancelled 117,833 and 463,468 common shares under the NCIB during Q4 2025 and FY 2025, respectively, for consideration of $0.4 million and $1.4 million.Notice of Conference Call EcoSynthetix will host a conference call Friday, February 20, at 8:30 am ET to discuss its financial results. Jeff MacDonald, CEO, and Robert Haire, CFO, will co-chair the call. All interested parties can instantly join the call by phone, by following the URL https://emportal.ink/4qPezGo to easily register and be connected into the conference call automatically or the conventional method by dialling (416) 945-7677 or (888) 699-1199 with the conference identification of 88814#. Please dial in 15 minutes prior to the call to secure a line. A live audio webcast of the conference call will also be available at www.ecosynthetix.com or https://app.webinar.net/OevLwVYga79. The presentation will be accompanied by slides, which will be available via the webcast link and the Company's website. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast.1Non-IFRS Financial MeasuresThis press release makes reference to certain non-IFRS measures. These non-IFRS measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing a further understanding of results of operations of EcoSynthetix from management's perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the financial information of EcoSynthetix reported under IFRS. The Company uses non-IFRS measures such as Adjusted EBITDA to provide investors with a supplemental measure of operating performance and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also believes that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of issuers. Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess the Company's ability to meet its capital expenditure and working capital requirements.Adjusted EBITDA is not a measure recognized under IFRS and does not have a standardized meaning prescribed by IFRS. See "IFRS and Non-IFRS Measures." The Company presents Adjusted EBITDA because the Company believes it facilitates investors' use of operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting relative interest expense), the book amortization of intangibles (affecting relative amortization expense) and the age and book value of property and equipment (affecting relative depreciation expense). The Company also presents Adjusted EBITDA because it believes it is frequently used by securities analysts, investors and other interested parties as a measure of financial performance. Adjusted EBITDA as presented herein are not recognized measures under IFRS and should not be considered as an alternative to operating income or net income as measures of operating results or an alternative to cash flows as measures of liquidity. Adjusted EBITDA is defined as consolidated net income (loss) before net interest expense, income taxes, depreciation, amortization, gain or loss on disposals of property, plant and equipment and other non-cash expenses and charges deducted in determining consolidated net income (loss).The following table reconciles net income (loss) to Adjusted EBITDA (loss) for the three and twelve months ended December 31, 2025, and December 31, 2024:
Three months ended
December 31, 2025Three months ended
December 31, 2024Twelve months ended
December 31, 2025Twelve months ended
December 31, 2024Net income (loss)152,753(206,884)(433,797)(1,366,926)Depreciation357,105352,1621,168,8161,164,739Share-based compensation260,906362,4401,042,2391,158,583Gain on disposal of property, plant and equipment ---(90,000)Interest income(292,855)(415,377)(1,360,369)(1,724,441)Adjusted EBITDA (loss)477,90992,341416,889(858,045)About EcoSynthetix Inc. (www.ecosynthetix.com) EcoSynthetix offers a range of sustainable engineered biopolymers that allow customers to reduce their use of harmful materials, such as formaldehyde and styrene-based chemicals. The Company's flagship products, DuraBind™, Surflock™, Bioform™, and EcoSphere®, are used to manufacture wood composites, personal care, paper, tissue and packaging products, and enable performance improvements, economic benefits and carbon footprint reduction. The Company is publicly traded on the Toronto Stock Exchange (T:ECO).Forward-Looking StatementsCertain statements in this Press Release constitute "forward-looking" statements that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, objectives or achievements of the Company, or industry results, to be materially different from any future results, performance, objectives or achievements expressed or implied by such forward looking statements. The forward-looking statements in this Press Release include, but are not limited to, statements regarding the Company's plans to execute its commercial strategy, deliver meaningful growth across all three product categories, convert high-value strategic prospects into customers, and other statements regarding the Company's plans and expectations in 2026. These statements reflect our current views regarding future events and operating performance and are based on information currently available to us, and speak only as of the date of this Press Release. These forward-looking statements involve a number of risks, uncertainties and assumptions and should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such performance or results will be achieved. Those assumptions and risks include, but are not limited to, the Company's ability to successfully allocate capital as needed and to develop new products, as well as the fact that our results of operations and business outlook are subject to significant risk, volatility and uncertainty. Many factors could cause our actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including the factors identified in the "Risk Factors" section of the Company's Annual Information Form dated February 17, 2026. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described in this Press Release as intended, planned, anticipated, believed, estimated or expected. Unless required by applicable securities law, we do not intend and do not assume any obligation to update these forward-looking statements.EcoSynthetix Inc.
Consolidated Balance Sheets
(expressed in US dollars)
December 31,
2025December 31,
2024Assets
Current assets
Cash8,420,2857,721,403Term deposits21,161,14524,473,985Accounts receivable 3,234,9112,325,369Inventory3,767,6612,828,748Prepaid expenses204,27290,306
36,788,27437,439,811
Non-current assets
Property, plant and equipment 5,943,2423,845,010
Total assets42,731,51641,284,821
Liabilities
Current liabilities
Trade accounts payables and accrued liabilities 2,355,3581,938,831
Non-current liabilities
Lease liability1,786,798-
Total liabilities4,142,1561,938,831Shareholders' Equity
Common shares 488,725,570489,246,909Contributed surplus11,211,81011,013,304Accumulated deficit(461,348,020)(460,914,223)Total shareholders' equity 38,589,36039,345,990
Total liabilities and shareholders' equity 42,731,51641,284,821 EcoSynthetix Inc.
Consolidated Statements of Operations and Comprehensive Income (Loss)
For the three and twelve months ended December 31, 2025 and 2024
(expressed in US dollars)
Three months ended December 31,
Twelve months ended December 31,
20252024
20252024
Net sales5,916,8225,432,916
20,797,09018,536,670
Cost of sales3,913,2533,861,435
14,761,16313,229,567
Gross profit on sales2,003,5691,571,481
6,035,9275,307,103
Expenses
Selling, general and administrative1,714,2471,836,858
6,200,7366,479,298Research and development429,424356,884
1,629,3572,009,172
2,143,6712,193,742
7,830,0938,488,470
Loss from operations(140,102)(622,261)
(1,794,166)(3,181,367)
Net interest income292,855415,377
1,360,3691,724,441Gain on disposal of property, plant and equipment--
-90,000Net income (loss) and comprehensive income (loss)152,753(206,884)
(433,797)(1,366,926)
Basic and diluted income (loss) per common share 0.00(0.00)
(0.01)(0.02)Weighted average number of common shares outstanding 58,546,27658,593,194
58,581,98658,667,534 EcoSynthetix Inc.
Consolidated Statements of Cash Flows
For the three and twelve months ended December 31, 2025 and 2024
(expressed in US dollars)
Three months ended December 31,
Twelve months ended December 31,
20252024
20252024Cash provided by (used in)
Operating activities
Net income (loss) and comprehensive income (loss)152,753(206,884)
(433,797)(1,366,926)Items not affecting cash
Depreciation357,105352,162
1,168,8161,164,739 Share-based compensation 260,906362,440
1,042,2391,158,583 Other (90,155)32,383
(215,462)8,015Gain on disposal of property, plant and equipment--
-(90,000)Changes in non-cash working capital
Accounts receivable(848,282)(77,875)
(909,542)(775,926) Inventory288,425(524,005)
(976,863)825,269 Prepaid expenses219,28870,045
(113,966)1,611 Trade accounts payables and accrued liabilities(497,543)(561,452)
124,416536,415Interest on term deposits
Interest received on term deposits90,36249,007
1,423,6841,223,981 Accrued interest on term deposits(239,240)(375,685)
(1,133,070)(1,581,201)
(306,381)(879,864)
(23,545)1,104,560
Investing activities
Purchase of property, plant and equipment(339,597)(154,514)
(846,315)(868,453)Proceeds on disposal of property, plant and equipment--
-90,000Receipts on matured term deposits-3,750,000
26,500,00031,550,000Purchase of term deposits--
(23,477,774)(27,300,000)
(339,597)3,595,486
2,175,9113,471,547
Financing activities
Payments made on lease liability(81,695)(78,597)
(320,476)(317,106)Common shares repurchased(359,222)(514,426)
(1,408,310)(2,175,924)Exercise of common share options-49,903
43,238760,362
(440,917)(543,120)
(1,685,548)(1,732,668)
Effect of exchange rate changes on cash 94,614(50,974)
232,064(37,481)
Change in cash during the period (992,281)2,121,528
698,8822,805,958
Cash - Beginning of period9,412,5665,599,875
7,721,4034,915,445
Cash - End of period 8,420,2857,721,403
8,420,2857,721,403
SOURCE EcoSynthetix Inc.
Original: EcoSynthetix Reports 2025 Fourth Quarter and Year End Results